We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
BILL Holdings
BILL
$5.11B
| $43.6K | ﹤0.01% |
799
-79
| -9% | -$4.06K |
|
|
NTST
1427
NETSTREIT Corp
NTST
$2.09B
| $43K | ﹤0.01% |
2,440
+650
| +36% | +$11.8K |
|
|
GTY
1428
Getty Realty Corp
GTY
$2.05B
| $43K | ﹤0.01% |
1,572
+418
| +36% | +$11.6K |
|
|
MESO
1429
Mesoblast
MESO
$2.14B
| $43K | ﹤0.01% |
2,383
+558
| +31% | +$9.6K |
|
|
ESPR
1430
DELISTED
Esperion Therapeutics
ESPR
| $43K | ﹤0.01% |
11,617
+3,822
| +49% | +$12.3K |
|
1431
Brunswick
BC
$5.29B
| $42.9K | ﹤0.01% |
578
-2
| -0.3% | -$136 |
|
|
TIGR
1432
UP Fintech Holding
TIGR
$833M
| $42.9K | ﹤0.01% |
4,487
+69
| +2% | +$659 |
|
1433
Harley-Davidson
HOG
$2.9B
| $42.4K | ﹤0.01% |
2,067
-1,051
| -34% | -$25.8K |
|
|
SGI
1434
Somnigroup International
SGI
$14B
| $41.7K | ﹤0.01% |
+467
| New | +$40.8K |
|
1435
TechnipFMC
FTI
$30.1B
| $41.2K | ﹤0.01% |
+925
| New | +$39.1K |
|
1436
Geron
GERN
$982M
| $40.9K | ﹤0.01% |
31,020
+6,354
| +26% | +$7.97K |
|
1437
Vir Biotechnology
VIR
$1.52B
| $40.8K | ﹤0.01% |
6,761
+1,390
| +26% | +$8.28K |
|
1438
ArriVent BioPharma
AVBP
$1.4B
| $40.4K | ﹤0.01% |
2,006
+438
| +28% | +$9.12K |
|
1439
Janux Therapeutics
JANX
$978M
| $40.3K | ﹤0.01% |
2,923
+600
| +26% | +$14.1K |
|
|
KALV
1440
DELISTED
KalVista Pharmaceuticals
KALV
| $39.7K | ﹤0.01% |
2,456
+510
| +26% | +$6.75K |
|
|
XHR
1441
Xenia Hotels & Resorts
XHR
$1.76B
| $39.6K | ﹤0.01% |
2,799
+636
| +29% | +$8.67K |
|
1442
Polaris
PII
$3.91B
| $39.5K | ﹤0.01% |
+625
| New | +$41.2K |
|
|
DOYU
1443
DouYu International Holdings
DOYU
$136M
| $39.3K | ﹤0.01% |
5,780
| – | – |
|
1444
Pebblebrook Hotel Trust
PEB
$2.05B
| $39.2K | ﹤0.01% |
3,465
+865
| +33% | +$9.52K |
|
1445
Innovative Industrial Properties
IIPR
$1.67B
| $38.8K | ﹤0.01% |
819
+205
| +33% | +$10.6K |
|
1446
Oric Pharmaceuticals
ORIC
$1.42B
| $38.7K | ﹤0.01% |
4,732
+977
| +26% | +$11.2K |
|
1447
Thor Industries
THO
$4.11B
| $38.4K | ﹤0.01% |
374
-125
| -25% | -$13K |
|
1448
Aquestive Therapeutics
AQST
$533M
| $38.3K | ﹤0.01% |
5,929
+1,252
| +27% | +$7.8K |
|
1449
Howard Hughes
HHH
$4.04B
| $38.3K | ﹤0.01% |
480
-1,430
| -75% | -$118K |
|
1450
GH Research
GHRS
$1.94B
| $38.3K | ﹤0.01% |
+3,014
| New | +$41.1K |
|
Similar funds
BC
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.